Epilepsy Trial, Recruiting NCT05393518 Sponsor: University Hospital, Bordeaux Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT05393518
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a man or woman between 18 and 65 years old
  • You have epilepsy that has not been controlled by medication (drug-resistant epilepsy)
  • You are already scheduled for a specific type of pre-surgery brain assessment that involves placing electrodes inside the brain to record electrical activity (called stereo-EEG)
  • You either do or do not meet the medical criteria for generalized anxiety disorder — both groups may be eligible
  • You have an IQ score above 75, or a related cognitive score above 81 (confirm with trial site)
  • You are covered by a social security or health insurance scheme
  • You are willing and able to give written informed consent to participate

Who may not be able to join:

  • You are not able to give your own consent to participate
  • You are under a legal protection order, such as guardianship or curatorship
  • You have a long-term condition involving delusions, such as schizophrenia
  • You have a moderate or high risk of suicide, as assessed by specific psychiatric screening tools used by the trial team
  • You are currently pregnant or breastfeeding
  • You have a serious or unstable physical health condition other than your epilepsy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jérôme Aupy, Dr, University Hospital, Bordeaux

Phone: 05 56 79 56 79

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 October 2022
Est. completion
11 October 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in neuronal coherence in the frontolimbic network

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov